No insder trading, this is a a fully underwriter ipo, meaning the underwriter has the responsibility to sell these shares. They have already sold them, I would guess that a bidding war took place for the shares and that doubled the share price.
Fact BNTC technology is the most valuable to the future. Genetic therapy is the future, all other email companies not using the cell to produce the drug will suffer as the cost to produce the drug outside the cell well be exponentially greater. Time I the only factor, and anyone with a bodily or masterful understanding of biology and accounting should understand this
BLT Price at posting:
92.0¢ Sentiment: Hold Disclosure: Not Held
